Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

NCT03298087 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

FED

Sponsor class

Conditions

Newly Diagnosed Oligometastatic Prostate Cancer

Interventions

PROCEDURE: radical prostatectomy
RADIATION: stereotactic body radiotherapy
DRUG: Leuprolide
DRUG: apalutamide
DRUG: abiraterone

Sponsor

VA Office of Research and Development